A Single-Center Open-Label Randomized Pilot Study of the Safety and Efficacy of AzaSite [azithromycin] Ophthalmic Solution 1% in Combination With Mechanical Therapy Versus Mechanical Therapy Alone for Two Weeks in Subjects With Posterior Blepharitis

Trial Profile

A Single-Center Open-Label Randomized Pilot Study of the Safety and Efficacy of AzaSite [azithromycin] Ophthalmic Solution 1% in Combination With Mechanical Therapy Versus Mechanical Therapy Alone for Two Weeks in Subjects With Posterior Blepharitis

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Sep 2011

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Bacterial infections; Infectious blepharitis
  • Focus Therapeutic Use
  • Sponsors Inspire Pharmaceuticals
  • Most Recent Events

    • 16 Nov 2009 Merck as company and lead trial centre identified as reported by ClinicalTrials.gov.
    • 09 Jan 2009 Status changed from active, no longer recruiting to completed.
    • 01 Sep 2008 Final results were published in Adv Ther 2008; 25(9):858-870.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top